Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis Alejandro Balsa; Petra Díaz del Campo Fontecha; Lucía Silva Fernández; José Valencia Martín; Virginia Nistal Martínez; Fernando León Vázquez; M. Vanesa Hernández Hernández; Héctor Corominas; Rafael Cáliz Cáliz; José María Aguado García; Gloria Candelas Rodríguez; Nora Ibargoyen Roteta; Arturo Martí Carvajal; M. Nieves Plana Farras; Janet Puñal Riobóo; Hye Sang Park; Yolanda Triñanes Pego; Virginia Villaverde García;

Safety and effectiveness of bDMARDs during pregnancy in patients with rheumatic diseases: Real-world data from the BIOBADASER registry Cristina Membrive-Jiménez; Carlos Sánchez-Piedra; Olga Martínez-González; Javier García-González; Lorena Expósito-Pérez; Cristina Bohórquez-Heras; Cristina Campos-Fernández; Fernando Sanchez-Alonso; Rafael Cáliz-Cáliz; Isabel Castrejón-Fernández;

What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment Sara Murias; Alina Boteanu; Inmaculada Calvo; Esmeralda Nuñez; Beatriz Bravo; Sagrario Bustabad; Marisol Camacho; Daniel Clemente; Jenaro Graña; Jaime de Inocencio; Lucía Lacruz; Pablo Mesa-del-Castillo; Juan Carlos Nieto-González; María del Carmen Pinedo; Estefanía Quesada; Carmen Vargas; Jordi Antón;